Insider Transactions in Q2 2023 at Beam Therapeutics Inc. (BEAM)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 04
2023
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
11,654
-7.3%
|
$337,966
$29.43 P/Share
|
|
Apr 04
2023
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,161
-1.38%
|
$33,669
$29.09 P/Share
|
|
Apr 04
2023
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
1,754
-1.54%
|
$50,866
$29.09 P/Share
|
|
Apr 04
2023
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
6,493
-0.58%
|
$188,297
$29.09 P/Share
|
|
Apr 04
2023
|
Terry Ann Burrell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,186
-4.43%
|
$63,394
$29.09 P/Share
|
|
Apr 03
2023
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,445
-5.2%
|
$133,350
$30.31 P/Share
|
|
Apr 03
2023
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
931
-1.1%
|
$27,930
$30.31 P/Share
|
|
Apr 03
2023
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
1,918
-1.65%
|
$57,540
$30.31 P/Share
|
|
Apr 03
2023
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
5,161
-0.46%
|
$154,830
$30.31 P/Share
|
|
Apr 03
2023
|
Terry Ann Burrell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,454
-4.74%
|
$73,620
$30.31 P/Share
|